Hexarelin Protocol: Complete Cycling & Dosing Guide

Overview

Hexarelin is a synthetic hexapeptide growth hormone secretagogue that stimulates endogenous GH release through agonism at the GHSR-1a (ghrelin) receptor. Unlike GHRH analogs, it also binds to CD36 scavenger receptors, providing distinct cardioprotective effects independent of the GH pathway. The compound is administered via subcutaneous or intramuscular injection and operates in the dose range of 100-200 mcg per injection.

Important disclaimer: This guide is educational content only and should not be construed as medical advice. Hexarelin is a research peptide not approved for therapeutic use in most jurisdictions. Consult a healthcare provider before use, especially if you have hormone-sensitive conditions, diabetes, or active malignancy.

The practical appeal of hexarelin lies in its robust GH-releasing capacity even in populations with blunted GH responsiveness (such as obese individuals or the elderly), its relatively short injection window (~15-30 minutes between administration and GH peak), and emerging evidence for cardioprotective effects. However, meaningful limitations exist: chronic use elevates prolactin and cortisol with each dose, water retention is common, and long-term safety data are sparse.

Standard Protocol

Baseline Dosing Architecture

The most commonly implemented protocol uses 100-200 mcg administered once to twice daily via subcutaneous injection. This range reflects clinical study data and practical tolerability thresholds.

Once-daily protocol:

• 100-150 mcg, typically injected in the morning 30-60 minutes before breakfast
• Simpler adherence profile; lower cumulative hormone elevation
• Suitable for users prioritizing cardioprotective effects with minimal systemic load

Twice-daily protocol:

• 100-150 mcg in the morning and evening (approximately 12 hours apart)
• Higher cumulative GH stimulus; greater anabolic drive
• Increases prolactin and cortisol elevation; requires closer monitoring

Cycle Structure

Hexarelin responds well to 6-12 week on/off cycling to manage prolactin and cortisol accumulation:

• Standard cycle: 8 weeks on, 4 weeks off
• Conservative approach: 6 weeks on, 2 weeks off (repeating)
• Aggressive protocol: 12 weeks on, 2-3 weeks off (advanced users only)

The off-phase allows suppressed endogenous GH and prolactin normalization. Cortisol typically rebounds within 1-2 weeks of cessation.

Reconstitution for Injectable Hexarelin

Hexarelin is typically supplied as lyophilized powder requiring reconstitution:

1. Obtain bacteriostatic water (0.9% sodium chloride with benzyl alcohol) or sterile saline
2. Calculate volume: For a 2 mg vial with target concentration of 100 mcg/mL, add 20 mL bacteriostatic water
3. Reconstitution method:
   • Draw bacteriostatic water into sterile syringe
   • Slowly inject into the vial along the vial wall (not directly onto powder)
   • Gently swirl (do not shake vigorously) until powder fully dissolves
   • Solution should be clear and colorless
4. Storage: Refrigerate reconstituted solution at 2-8°C; stability typically 30 days
5. Pre-reconstituted solutions: If purchased pre-made, store at 2-8°C and verify expiration date

Injection Technique

Site selection: Rotate between abdomen, upper thigh, and upper arm subcutaneous tissue to prevent lipohypertrophy.

Injection procedure:

1. Clean injection site with alcohol swab; allow 10 seconds to dry
2. Pinch skin fold between thumb and forefinger
3. Insert 27-29 gauge needle at 45-degree angle into subcutaneous layer
4. Inject slowly over 5-10 seconds
5. Withdraw needle; apply light pressure for 5 seconds
6. Vary injection sites daily to prevent tissue damage

Intramuscular option: Some users report faster absorption via shallow IM injection (deltoid, vastus lateralis), though this increases localized inflammation risk.

Goal-Specific Protocols

Protocol A: Cardioprotection & General Health

Objective: Maximize cardiac benefits with minimal hormonal burden

• Dose: 100 mcg once daily (morning)
• Timing: 30 minutes before light breakfast
• Cycle: 8 weeks on, 4 weeks off
• Frequency: 7 days per week (no off-days)
• Adjuncts: Consider pairing with CoQ10 (200-300 mg/day) and L-carnitine (2-3 g/day) to support cardiac energetics
• Monitoring: Check prolactin and cortisol at weeks 4 and 8; assess subjective markers (blood pressure, heart rate variability, exercise tolerance)

Rationale: Single daily dosing provides sufficient GH stimulus to trigger cardioprotective CD36 signaling while minimizing cumulative prolactin and cortisol elevation. Clinical data shows acute hexarelin improves left ventricular ejection fraction and cardiac output independent of GH magnitude.

Protocol B: Muscle & Recovery (Anabolic Focus)

Objective: Drive lean mass gains and tissue repair

• Dose: 150 mcg twice daily (morning and evening)
• Timing: 6 AM and 6 PM, 30-60 minutes before meals
• Cycle: 8 weeks on, 3 weeks off
• Frequency: 5-6 days per week (optional 1-2 rest days for prolactin management)
• Adjuncts: Combine with resistance training 4-5x/week; consider GHRH analog (tesamorelin or CJC-1293) at evening injection for synergistic GH response
• Nutrition: Ensure 1.6-2.2 g protein per kg bodyweight; caloric surplus of 300-500 kcal above maintenance
• Monitoring: Track body composition (DEXA or bioimpedance at weeks 0, 4, 8); monitor prolactin every 4 weeks

Rationale: Twice-daily dosing amplifies GH pulses, driving hepatic IGF-1 production and downstream anabolic signaling. Evidence from animal models shows hexarelin supports mitochondrial biogenesis and muscle proteostasis, particularly beneficial in resistance-trained individuals.

Protocol C: Metabolic Health & Liver Support

Objective: Improve glucose tolerance, reduce hepatic triglycerides, enhance insulin sensitivity

• Dose: 100 mcg once daily (morning)
• Timing: 30 minutes before breakfast; fasted state preferred
• Cycle: 6 weeks on, 2 weeks off (repeating)
• Frequency: 7 days per week
• Adjuncts: Add berberine (500 mg, 2-3x daily) and inositol (4-5 g/day myo-inositol, 1-2 g/day D-chiro-inositol) for synergistic glucose control
• Nutrition: Low glycemic index diet; moderate carbohydrate intake (3-5 g/kg bodyweight)
• Monitoring: Fasting glucose, insulin, and lipid panel at baseline, week 3, and week 6; assess subjective hunger changes

Rationale: Animal studies demonstrate hexarelin reduces plasma and hepatic triglycerides while improving glucose/insulin tolerance in insulin-resistant models. Once-daily dosing minimizes cortisol elevation, which could counteract metabolic improvements.

Protocol D: Anti-Inflammatory & Immune Support

Objective: Harness anti-inflammatory effects; support recovery from acute injury or illness

• Dose: 100-150 mcg once to twice daily
• Timing: Morning; additional evening injection if twice-daily
• Cycle: 4-6 weeks on, 2-3 weeks off
• Frequency: 5-7 days per week depending on inflammatory trigger
• Adjuncts: Combine with omega-3 fatty acids (2-3 g EPA/DHA daily), curcumin (500-1000 mg 2-3x daily), and vitamin D3 (2000-4000 IU/day)
• Monitoring: CRP, TNF-α, IL-1β if accessible; track subjective inflammation markers (joint pain, swelling, recovery speed)

Rationale: Hexarelin reduces TNF-α and IL-1β in cardiac injury models and suppresses fibrotic TGF-β1 expression. Short-cycle implementation allows anti-inflammatory benefits while limiting hormonal disruption.

How to Administer Step-by-Step

Pre-Injection Checklist

1. Verify solution quality: Ensure clear, colorless appearance; discard if cloudy, discolored, or contains particulates
2. Check expiration: Confirm reconstituted solution is within 30-day window (pre-made solutions should have dated labels)
3. Prepare workspace: Clean flat surface; gather sterile syringe, needle, alcohol swab, and sharps container
4. Select rotation site: Different location each injection to prevent lipohypertrophy
5. Wash hands: Standard hand hygiene

Injection Steps

1. Draw dose: Insert needle into vial; withdraw plunger to desired volume (e.g., 1 mL for 100 mcg at 100 mcg/mL concentration)
2. Expel air: Hold syringe upright; tap syringe gently to consolidate air bubbles at needle hub; expel air bubble
3. Prepare site: Clean injection area with alcohol swab in circular motion (3-inch radius); wait 10-15 seconds for evaporation
4. Pinch skin: Create raised fold of subcutaneous tissue
5. Insert needle: Angle 45 degrees; insert smoothly to subcutaneous depth (approximately 0.5 inches)
6. Inject solution: Push plunger steadily over 5-10 seconds
7. Withdraw needle: Remove smoothly; immediately apply pressure with alcohol swab for 5 seconds
8. Dispose safely: Place used syringe and needle in sharps container; never recap

Timing Optimization

Pre-meal injection: Inject 30-60 minutes before eating to maximize GH release in fasted state without competition from ingested nutrients

Post-workout injection: Some users inject immediately post-resistance training to amplify GH-mediated recovery signaling, though evidence for superior timing is mechanistic rather than validated

Cycle Example: 8-Week Anabolic Protocol

What to Expect: Timeline of Effects

Acute Response (Within 15-30 Minutes)

• GH pulse: Growth hormone rises 10-20 fold above baseline within 15 minutes; peaks at 20-30 minutes
• Appetite stimulation: Noticeable hunger increase via ghrelin pathway activation; typically peaks at 30-45 minutes
• Subjective warmth: Mild flushing or sensation of warmth in face/chest in some users

1-2 Week Timeframe

• Water retention: Noticeable fluid accumulation, particularly in face and extremities; typically 2-5 lbs
• Increased appetite: Persistent elevation in hunger signaling throughout the day
• Sleep quality: May experience deepened sleep or slight sedation, though prolactin elevation can disrupt REM sleep in some users
• Cortisol elevation: Transient rise post-injection; may contribute to daytime alertness

3-4 Week Timeframe

• Strength performance: Improved recovery between sessions; possible early strength gains in resistance-trained users
• Joint and connective tissue: Subjective reduction in creaking, improved mobility
• Body composition changes: Minimal fat loss noted; potential lean mass stabilization from improved recovery
• Carpal tunnel symptoms: Tingling or numbness in wrists/hands may emerge in 5-15% of users; typically mild but can progress with continuation

6-8 Week Timeframe

• Lean mass gains: Measurable increases in lean tissue mass (2-5 lbs in anabolic protocols with adequate training and nutrition)
• Cardiovascular improvements: Enhanced cardiac output subjectively reported; improved exercise tolerance
• Prolactin effects: Gynecomastia risk increases with continued use; potential mood changes or decreased libido in sensitive individuals
• Metabolic adaptations: Insulin sensitivity improvements evident in metabolic protocols; triglyceride reduction possible
• Fatigue onset: Cumulative fatigue or lethargy may emerge, particularly with twice-daily dosing; signals need for cycle cessation

Common Protocol Mistakes

Mistake 1: Injecting Too Frequently

Error: Some users administer 3+ times daily or every 8 hours, believing more frequent GH pulses yield superior results.

Problem: Prolactin and cortisol accumulation accelerates, increasing side effect risk (gynecomastia, mood disruption, sleep fragmentation) without proportional anabolic benefit. GH response exhibits diminishing returns beyond twice-daily administration.

Solution: Adhere to maximum twice-daily dosing; space injections 12 hours apart.

Mistake 2: Neglecting Off-Cycles

Error: Running hexarelin continuously without planned breaks, assuming sustained GH stimulus = sustained results.

Problem: Prolactin and cortisol chronically elevated; endogenous GH suppression may worsen; tolerance to GH-releasing effect possible (though less likely than with CJC/GHRH analogs).

Solution: Implement 2-4 week off-phases every 6-12 weeks; allows hormonal normalization and prevents accommodation.

Mistake 3: Dose Escalation Beyond 200 mcg

Error: Increasing individual dose to 250-300+ mcg seeking greater GH response.

Problem: Prolactin and cortisol elevation plateau—higher doses don't produce proportionally higher GH peaks in humans. Side effect burden increases disproportionately.

Solution: Stay within 100-200 mcg per injection; modulate response via frequency (once vs. twice daily) and cycle duration rather than dose magnification.

Mistake 4: Improper Reconstitution & Storage

Error: Vigorous shaking during reconstitution; storing at room temperature; using reconstituted solution beyond 30-45 days.

Problem: Peptide denaturation; reduced potency; bacterial contamination risk.

Solution: Gentle swirling during reconstitution; refrigerate immediately at 2-8°C; date vials clearly; discard after 30 days.

Mistake 5: Injecting Without Nutrition/Training Strategy

Error: Administering hexarelin without concurrent resistance training or adequate protein intake.

Problem: Anabolic benefits unrealized; IGF-1 elevation without mechanical stimulus or amino acid availability wastes GH secretion stimulus.

Solution: Combine with 4+ resistance training sessions weekly and 1.6-2.2 g protein per kg bodyweight; ensure caloric environment matches goal (surplus for growth, maintenance for recomposition).

How to Stack with Other Compounds

Hexarelin + GHRH Analogs (CJC-1293, Tesamorelin)

Synergy: GHRH + GHS (hexarelin) act on complementary pathways—GHRH stimulates GH release from anterior pituitary; hexarelin amplifies pituitary responsiveness. Combined response exceeds additive effect of individual compounds.

Protocol:

• Hexarelin: 100 mcg, morning
• GHR